Skip to main content

Home > Releases > Quarterly Financial Report > Quarterly Financial Report: U.S. Corporations: Pharmaceuticals and Medicines: Net Sales, Receipts, and Operating Revenues

Quarterly Financial Report: U.S. Corporations: Pharmaceuticals and Medicines: Net Sales, Receipts, and Operating Revenues (QFR101385USNO)

Observations

Q4 2024: 176,881
Updated: Mar 24, 2025 9:08 AM CDT
Q4 2024:  176,881  
Q3 2024:  174,351  
Q2 2024:  164,058  
Q1 2024:  153,567  
Q4 2023:  158,791  

Units:

Millions of Dollars,
Not Seasonally Adjusted

Frequency:

Quarterly

Fullscreen

Notes

Title Release Dates
Quarterly Financial Report: U.S. Corporations: Pharmaceuticals and Medicines: Net Sales, Receipts, and Operating Revenues 2017-09-06 2025-03-24
 
Source    
U.S. Census Bureau 2017-09-06 2025-03-24
 
Release    
Quarterly Financial Report 2017-09-06 2025-03-24
 
Units    
Millions of Dollars 2017-09-06 2025-03-24
 
Frequency    
Quarterly 2017-09-06 2025-03-24
 
Seasonal Adjustment    
Not Seasonally Adjusted 2017-09-06 2025-03-24
 
Notes    
Further information related to the Quarterly Financial Report survey can be found at https://www.census.gov/econ/qfr/about.html
Methodology details can be found at https://www.census.gov/econ/qfr/documents/QFR_Methodology.pdf

2017-09-06 2025-03-24

Release Tables

Quarterly Financial Report

Related Data and Content

Data Suggestions Based On Your Search

Content Suggestions

Related Categories

Financial Activity Measures Financial Indicators Money, Banking, & Finance

Releases

More Series from Quarterly Financial Report

Tags

Medicines Pharmaceuticals Quarterly Financial Report Operating Receipts Revenue Chemicals Finance Nondurable Goods Corporate Net Sales Goods Manufacturing Industry Quarterly Census Nation Public Domain: Citation Requested Not Seasonally Adjusted United States of America